SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
SciClone Pharmaceuticals (Holdings) Ltd
Cash from Operating Activities
SciClone Pharmaceuticals (Holdings) Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Operating Activities
¥3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
108%
|
CAGR 10-Years
30%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Operating Activities
¥3.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Operating Activities
¥3.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Operating Activities
¥927.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is SciClone Pharmaceuticals (Holdings) Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.2B
CNY
Based on the financial report for Dec 31, 2023, SciClone Pharmaceuticals (Holdings) Ltd's Cash from Operating Activities amounts to 1.2B CNY.
What is SciClone Pharmaceuticals (Holdings) Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
48%
Over the last year, the Cash from Operating Activities growth was 0%. The average annual Cash from Operating Activities growth rates for SciClone Pharmaceuticals (Holdings) Ltd have been 6% over the past three years , 48% over the past five years .